Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Summary

RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving idarubicin together with high-dose cytarabine works in treating patients with acute myeloid leukemia.

Timeline

Start

1994-09

Primary completion

2015-12

Completion

2015-12

Drugs

Indications